These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21955433)

  • 1. Immunomodulation of inducible co-stimulator (ICOS) in human cytokine-induced killer cells against cholangiocarcinoma through ICOS/ICOS ligand interaction.
    He M; Wang Y; Shi WJ; Wang SJ; Sha HF; Feng JX; Wang J
    J Dig Dis; 2011 Oct; 12(5):393-400. PubMed ID: 21955433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible costimulator (ICOS) enhances the cytolytic activity of cytokine-induced killer cells against gallbladder cancer in vitro and in vivo.
    Wang J; He M; Shi W; Sha H; Feng J; Wang S; Wang Y
    Cancer Invest; 2009 Mar; 27(3):244-50. PubMed ID: 19194830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytokine-induced killer cells specifically infiltrated and retarded the growth of the inoculated human cholangiocarcinoma cells in SCID mice.
    Wongkajornsilp A; Somchitprasert T; Butraporn R; Wamanuttajinda V; Kasetsinsombat K; Huabprasert S; Maneechotesuwan K; Hongeng S
    Cancer Invest; 2009 Feb; 27(2):140-8. PubMed ID: 19235585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction of dendritic cells from intra-operative lost blood and their effects on CIK against liver cancer cells in vitro].
    DU Z; Zhao XL; Gao YT; Wu CX; Wang YJ; Zhu ZY; Sun Q; Fang SC
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):759-63. PubMed ID: 19173806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma-derived exosomes inhibit the antitumor activity of cytokine-induced killer cells by down-regulating the secretion of tumor necrosis factor-α and perforin.
    Chen JH; Xiang JY; Ding GP; Cao LP
    J Zhejiang Univ Sci B; 2016 Jul; 17(7):537-44. PubMed ID: 27381730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo].
    Ge W; Li CH; Zhang W; Han Q; Deng WM; Chen L; You SG; Zhao CH
    Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):277-80. PubMed ID: 15182535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis.
    Hasegawa M; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K
    Rheumatology (Oxford); 2013 Feb; 52(2):242-51. PubMed ID: 23024058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model.
    Du X; Jin R; Ning N; Li L; Wang Q; Liang W; Liu J; Xu Y
    Oncol Rep; 2012 Nov; 28(5):1743-9. PubMed ID: 22948809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR; Zager JS; Hezel M; Stanziale SF; Adusumilli PS; Gonen M; Ebright MI; Culliford A; Gusani NJ; Fong Y
    Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Achyranthes bidentata polysaccharides stimulated dendritic cells co-cultured with cytokine induced killer cells against SW480 cells].
    Zhou ZD; Xia DJ
    Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(7):1056-60. PubMed ID: 23847957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro.
    Morisaki T; Umebayashi M; Kiyota A; Koya N; Tanaka H; Onishi H; Katano M
    Anticancer Res; 2012 Jun; 32(6):2249-56. PubMed ID: 22641659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of dendritic cells co-cultured with cytokine induced killer cells on cytotoxicity against drug resistant K562 cells].
    Chen BA; Li M; Sun ZY; Li CP; Gao C; Sun YY; Wang J; Fu Q; Chen J
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):355-8. PubMed ID: 16185482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].
    Li H; Ren XB; Zhang P; An XM; Liu H; Hao XS
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(44):3134-8. PubMed ID: 16405818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proliferation and cytotoxicity of RetroNectin-activated cytokine-induced killer cells against cisplatin-resistant lung carcinoma cell].
    Ren W; Wang Z
    Sheng Wu Gong Cheng Xue Bao; 2008 Aug; 24(8):1373-80. PubMed ID: 18998538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The anti-tumor effects of dendritic cells co-cultured with cytokine induced killer cells after chemotherapy].
    Zhang S; Zhang SQ; Bai CX
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 May; 27(5):315-9. PubMed ID: 15196340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
    Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway.
    Tanaka C; Fujimoto M; Hamaguchi Y; Sato S; Takehara K; Hasegawa M
    Arthritis Rheum; 2010 Jun; 62(6):1723-32. PubMed ID: 20191584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study.
    Chan JK; Hamilton CA; Cheung MK; Karimi M; Baker J; Gall JM; Schulz S; Thorne SH; Teng NN; Contag CH; Lum LG; Negrin RS
    Clin Cancer Res; 2006 Mar; 12(6):1859-67. PubMed ID: 16551871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apoptotic and proliferative fate of cytokine-induced killer cells after redirection to tumor cells with bispecific Ab.
    Kornacker M; Verneris M; Kornacker B; Ganten T; Scheffold C; Negrin R
    Cytotherapy; 2006; 8(1):13-23. PubMed ID: 16627341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.